ALLIANCE E-NEWS

FALL 2016 | VOLUME 6, NUMBER 4

Registration Now Open forAlliance Fall Group Meeting

The Alliance for Clinical Trials in Oncology will convene its2016 Fall Group Meeting in Chicago November 2-5. Scientists,clinical research professionals, patient advocates and othersinterested in the latest developments in cancer research areexpected to attend the four-day meeting at the Loews ChicagoO'Hare Hotel. Meeting attendees will select from nearly 100disease, modality, administrative and special sessions to attendled by distinguished oncology researchers and clinical trialspecialists from across the country. This meeting will showcasenovel and innovative cancer control, prevention, and treatmenttrials that are conducted by investigators through amultidisciplinary academic and community research network,which is part of the NCI National Clinical Trials Network (NCTN)and Community Oncology Research Program (NCORP).Read more

IN MEMORIAM

MEETINGS

2016 - Fall - November 2-5 | Chicago2017 - Spring & Fall - May 11-13 | Chicago - November 2-4 | Chicago

ANNOUNCEMENTSAlliance Executive CommitteeSelects New Committee Chairs

Recent Alliance ProtocolActivations Through October 1

DID YOU KNOW...A Searchable Listing ofPublished Manuscripts +Abstracts is on Alliance PublicWebsite

There's a the Handy AllianceGlossary of Abbreviations,Acronyms and Terminologyeasily accessible on both AlliancePublic and Member Websites

Information about AllianceFoundation Trials is available atwww.AllianceFoundationTrials.org

Visit our website Learn more about what'shappening in the Alliance,visit the Alliance websitetoday!

Sargent

Daniel J. Sargent, PhD, Principal Investigator, Statistics & DataManagement Program; GroupStatistician for Alliance

The cancer clinical researchcommunity suffered a tremendousloss on September 22, 2016 withthe passing of Daniel J. Sargent,PhD, due to a sudden unexpectedillness. Dan was a lifelong residentof Minnesota. He earned a BS inMathematics and PhD inBiostatistics from the University ofMinnesota, and then joined thefaculty of the Mayo Clinic Rochesterin 1996. At the time of his passing,he was the Ralph S. and BeverleyE. Caulkins Professor of CancerResearch, and the Chair of theDivision of Biomedical Statistics and

Informatics in the Department of Health Sciences Research at the MayoClinic. Dan was a world expert in the area of oncology clinical trials.Read more

FUNDING SUPPORTFour Investigators Receive FundingAwards Through the Alliance CancerControl Program

Jatio Navari

Stay Connected

Basch

Pagedar Hoffman

Four Alliance investigators have been selected to receive fundingawards through the Alliance Cancer Control Program (CCP). TheAlliance NCORP Research Base, which is supported by the NCIDivision of Cancer Prevention (DCP), supports Alliance researchersand junior investigators and their work through annual funding awards:Alliance CCP Pilot Project Award and Alliance CCP Junior FacultyAward. This year, three projects have been selected to receive the pilotproject award; however, none were selected for the junior faculty award.Read more

Alliance Researcher Approved for$5.45M Funding Award for Patient-Centered Research

An Alliance researcher has beenapproved for a multi-year funding awardfrom the Patient-Centered OutcomesResearch Institute (PCORI) to fundcomparative effectiveness research thatwill study electronic patient reporting ofsymptoms during outpatient cancertreatment. Ethan M. Basch, MD, MSc, isDirector of Cancer Outcomes ResearchProgram at the University of NorthCarolina-Chapel Hill LinebergerComprehensive Cancer Center, andProfessor in Department of Medicine inthe Division of Hematology and Oncologyat the UNC-Chapel Hill. He is a Co-Chair

of the Alliance Health Outcomes Committee and a member of theAlliance American College of Surgeons Clinical Research Program'sCancer Care Delivery Research Committee. Read more

NCI Selects Alliance Researcherto Co-Chair Cancer Care DeliveryResearch Coordinating Committee

Chang

George J. Chang, MD, MS, FACS,FASCRS, an Alliance researcher, has beennominated and selected to serve asCo-Chair for the National Cancer Institute'sCancer Care Delivery Research (CCDR)Coordinating Committee. He will join twoothers (Ruth Carlos, MD, and MatthewHudson, MD) in the co-chair positions. Dr.Chang is a Professor in the Department ofSurgical Oncology-Division of Surgery; Chiefin the Section of Colon and Rectal Surgery;Director of Clinical Operations for MinimallyInvasive and New Technologies in theOncologic Surgery Program; and AssociateMedical Director of the Colorectal Center atthe University of Texas MD Anderson Cancer Center. He is also Chairof the Alliance Cancer Care Delivery Research Committee, which ispart of the Alliance Cancer Control Program. Read more

SPOTLIGHT ON ALLIANCE TRIALSStereotactic Radiosurgery May BeBest for Patients with MetastaticBrain Tumors Patients with three or fewer metastatic brain tumors who receivedtreatment with stereotactic radiosurgery (SRS) had less cognitivedeterioration three months after treatment than patients who receivedSRS combined with whole brain radiation therapy (WBRT). Thesefindings are according to the results of an Alliance trial - NCCTGN107C A phase III trial of post-surgical stereotactic radiosurgerycompared with whole brain radiotherapy (WBRT) for resectedmetastatic brain disease - published recently in the Journal of theAmerican Medical Association.Read more

Alliance for Clinical Trials in Oncology

Copyright © 2016. All Rights Reserved.

Alliance for Clinical Trials in Oncology, Office of the Group Chair,221 Longwood Drive, Room 108, Boston, MA 02115